AeroLeads people directory · profile
Michael D. Email & Phone Number
Co-Founder
at
Delphia Therapeutics
LinkedIn matched
✓ Verified Jun 2026
3 data sources
Profile completeness 86%
Current company
Role
Co-Founder
Location
San Francisco Bay Area, United States, United States
Company size
Who is Michael D.? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Michael D. is listed as Co-Founder at Delphia Therapeutics, a company with 29 employees, based in San Francisco Bay Area, United States, United States. AeroLeads shows a matched LinkedIn profile for Michael D..
Michael D. previously worked as Chief Technology Officer at Curasen Therapeutics, Inc. and Associate at Crow Consulting. Michael D. holds Ph.D., Total Synthesis Of Natural Products from University Of Bristol.
Company email context
Email format at Delphia Therapeutics
This section adds company-level context without repeating Michael D.'s masked contact details.
Delphia Therapeutics
Review company-level records connected to Michael D. before choosing the right outreach path.
Profile bio
About Michael D.
Michael D. is a Co-Founder at Delphia Therapeutics.
Current workplace
Michael D.'s current company
Company context helps verify the profile and gives searchers a useful next step.
Delphia Therapeutics
13 roles
Michael D. work experience
A career timeline built from the work history available for this profile.
Chief Technology Officer
Current
Jan 2023 - Present
Co-Founder
Current
Jul 2022 - Present
Associate
Current
Crow Consulting
Bespoke consulting support specializing in small molecule drug discovery and preclinical development for a number of companies.
Dec 2021 - Present
Chief Scientific Advisor
Worked with the team to advance the lead program including the discovery and profiling of the clinical development candidate MOD246. Modifi Bio was acquired by Merck in October 2024. https://www.fiercebiotech.com/biotech/merck-moves-glioblastoma-13-billion-biobucks-purchase-modifi-biosciences
Mar 2022 - Oct 2024
Chief Scientific Officer, Head Of Research
Mar 2018 - Dec 2021
Senior Vice President, Head Of Drug Discovery
Mike was Chief Scientific Officer and Head of Research, at IDEAYA Biosciences in South San Francisco CA. Mike joined IDEAYA as the 3rd employee in 2016 and was responsible for establishing the drug discovery strategy, building the team, and selecting the early portfolio. Under his leadership IDEAYA grew to >80 employees and established itself as one of the.
Apr 2016 - Feb 2018
Global Head Oncology, Adc And New Modalities Chemistry
As Global Head Oncology Chemistry Mike was responsible for the scientific and strategic direction of large teams based in Cambridge MA, and Basel, Switzerland. In his global role Mike contributed across the portfolio where a number of compounds advanced into the clinic, including first-in-class EED inhibitor MAK683, allosteric SHP2 inhibitor TNO155 and.
Dec 2013 - Apr 2016
Executive Director Oncology Chemistry And Head, Chemical Sciences
Mike Dillon joined Novartis Institutes for BioMedical Research (NIBR) in November 2008 as Executive Director Oncology Chemistry and Head of Chemical Sciences at the Emeryville Research Site. Encompassing Medicinal, Analytical, Structural and Computational chemistry, in addition to Metabolism and Pharmacokinetics; Chemical Sciences, in close collaboration.
Nov 2008 - May 2014
Research Scientist - Director, Medicinal Chemistry
At Roche Mike held increasing levels of seniority focusing on the discovery and development of potential new medicines to treat pain, respiratory, inflammatory, CNS and viral diseases. He led a number of projects that advanced in to clinical development the most advanced of which is the first in class P2X3 antagonist AF219. Advanced in to Phase 2b by.
Oct 1993 - Nov 2008
Staff Researcher, Institute Of Bioorganic Chemistry
Mike joined Syntex shortly before their acquisition by Roche working on the synthesis of nucleosides as potential immunosuppressants to prevent rejection in organ transplantation.
Oct 1993 - Jan 1995
Post Doctoral Research Fellow
Total synthesis of Natural Products including completion of the first total synthesis of Byssochlamic acid
Dec 1991 - Aug 1993
Pre-University Industrial Scholar
Ici
Synthesis of complex carbohydrate and nucleoside derivatives for biological testing
Aug 1984 - Aug 1985
3 education records
Michael D. education
Ph.D., Total Synthesis Of Natural Products
B.Sc. (Hons), Chemistry
Education record
FAQ
Frequently asked questions about Michael D.
Quick answers generated from the profile data available on this page.
What company does Michael D. work for?
Michael D. works for Delphia Therapeutics.
What is Michael D.'s role at Delphia Therapeutics?
Michael D. is listed as Co-Founder at Delphia Therapeutics.
Where is Michael D. based?
Michael D. is based in San Francisco Bay Area, United States, United States while working with Delphia Therapeutics.
What companies has Michael D. worked for?
Michael D. has worked for Delphia Therapeutics, Curasen Therapeutics, Inc., Crow Consulting, Modifi Bio, and Ideaya Biosciences.
How can I contact Michael D.?
You can use AeroLeads to view verified contact signals for Michael D. at Delphia Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Michael D. attend?
Michael D. holds Ph.D., Total Synthesis Of Natural Products from University Of Bristol.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialPeople with similar names
Check these profiles if this is not the Michael D. you were looking for.
Michael R.
7 email domains
Michael D.
5 email domains
Michael Taiwo, Ph.D.
1 email domain
Michael D.
2 email domains
